Public Relations


"Starting with our proprietary positioning and messaging methodology – LHS Immersion® – we partner with clients to develop integrated communications’ programs that build influence and awareness and reach the right stakeholders, with the right messages at the right time."

--Sharon Correia

Our Public Relations services help our clients educate target audiences about their unique value proposition through corporate and product story development. We build influence and awareness to position our clients and/or their products as the right choice for critical stakeholders.
We provide:

Douglas Russell

Senior Vice President & General Manager

Phone: 617-374-8800 x108
Email: drussell@lavoiehealthscience.com

Sharon Correia

Senior Vice President, Integrated Communications

Phone: 617-374-8800 x105
Email: scorreia@lavoiehealthscience.com

Bell Ringer Merit Award 2016

PAIN: a conversation with highly-regarded speakers, digital content, advocacy group outreach, and media relations. The event drew a standing-room crowd, including several leaders and advocacy groups, to a premier Boston hotel for a networking reception and panel.

@LaVoieGroup

- 1 day ago

RT @big3bio: These workshops by @LaVoieGroup at #BIO2019 will help improve your talks with investors and partners. #Big4Bio #Philly #Start…
@LaVoieGroup

- 1 day ago

It's important for PR pros to forge meaningful relationships with journalists. Learn more about humanizing media re… https://t.co/m5mSQjbCaE
@LaVoieGroup

- 1 day ago

RT @dlavoie02: ⁦@LaVoieGroup⁩ we’re hiring passionate, professional and mature associates who want to grow long term with our team https:/…
@LaVoieGroup

- 2 days ago

RT @BulldogReporter: #PR Event News: Two @LaVoieGroup Workshops Announced for 2019 BIO International Convention https://t.co/7XwEdrXS2A #pu…

Example of Public Relations: Panel Development

PAIN: a Conversation brought together industry leaders to participate in a discussion about opioid addition and the need for alternatives. This panel discussion drew nearly 100 clinicians, scientists, patient advocates, patients, investors and biotech/pharma industry professionals.